183 related articles for article (PubMed ID: 2468936)
1. Effects of neuropeptide Y on contraction, relaxation, and membrane potential of rabbit cerebral arteries.
Abel PW; Han C
J Cardiovasc Pharmacol; 1989 Jan; 13(1):52-63. PubMed ID: 2468936
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelium in regulation of smooth muscle membrane potential and tone in the rabbit middle cerebral artery.
Yamakawa N; Ohhashi M; Waga S; Itoh T
Br J Pharmacol; 1997 Aug; 121(7):1315-22. PubMed ID: 9257909
[TBL] [Abstract][Full Text] [Related]
3. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
Han C; Abel PW
J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
[TBL] [Abstract][Full Text] [Related]
5. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
6. Relaxation of vascular smooth muscle by isoproterenol, dibutyryl-cyclic AMP and theophylline.
Webb RC; Bohr DF
J Pharmacol Exp Ther; 1981 Apr; 217(1):26-35. PubMed ID: 6259328
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting rabbit mesenteric artery smooth muscle sensitivity to calcium antagonists.
Meisheri KD; Sage GP; Cipkus-Dubray LA
J Pharmacol Exp Ther; 1990 Mar; 252(3):1167-74. PubMed ID: 2319466
[TBL] [Abstract][Full Text] [Related]
8. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
9. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
10. Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.
Prieto D; Buus C; Mulvany MJ; Nilsson H
J Physiol; 1997 Jul; 502 ( Pt 2)(Pt 2):281-92. PubMed ID: 9263910
[TBL] [Abstract][Full Text] [Related]
11. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
Owen MP
J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
Chataigneau T; Félétou M; Thollon C; Villeneuve N; Vilaine JP; Duhault J; Vanhoutte PM
Br J Pharmacol; 1998 Mar; 123(5):968-74. PubMed ID: 9535027
[TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
14. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous responses to vasodilators of dog proximal and distal middle cerebral arteries.
Toda N; Miyazaki M
J Cardiovasc Pharmacol; 1984; 6(6):1230-7. PubMed ID: 6084784
[TBL] [Abstract][Full Text] [Related]
16. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
17. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
Bawankule DU; Sathishkumar K; Sardar KK; Chanda D; Krishna AV; Prakash VR; Mishra SK
J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
[TBL] [Abstract][Full Text] [Related]
18. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y: vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage.
Abel PW; Han C; Noe BD; McDonald JK
Brain Res; 1988 Nov; 463(2):250-8. PubMed ID: 3196916
[TBL] [Abstract][Full Text] [Related]
20. Captopril inhibits ouabain-sensitive Na+/K+-ATPase.
Accetto R; Rinaldi G; Weder AB
Clin Physiol Biochem; 1989; 7(2):101-8. PubMed ID: 2547542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
